SMA Solar (S92) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
18 May, 2026Executive summary
Q1 2026 sales rose 4% year-over-year to €341 million, driven by strong growth in Home & Business Solutions (HBS) and stable performance in Large Scale & Project Solutions.
EBITDA increased to €26.1 million (7.7% margin), up from €24.6 million (7.5%) in Q1 2025, with operating EBITDA before one-offs up 67%.
Order backlog reached €1.41 billion, reflecting robust demand, especially in large-scale projects.
Free cash flow turned negative at €-27 million, mainly due to increased receivables, restructuring, and higher working capital.
Net income declined to -€1.6 million from €5.5 million year-over-year, mainly due to deferred tax expenses.
Financial highlights
HBS division sales grew 27% to €61 million; Large Scale division sales remained stable at €280 million.
EBIT for HBS improved to -€19.6 million from -€46 million, while Large Scale EBIT declined to €33.8 million from €50.3 million.
EBITDA margin improved to 7.7% from 7.5% year-over-year.
Net working capital ratio at 16%, with net working capital at €243 million.
Net cash position decreased to €148 million, down from €176.4 million at year-end 2025.
Outlook and guidance
FY 2026 sales guidance refined to €1,475–1,675 million, with EBITDA expected between €50–180 million, both anticipated in the upper third of the range.
Large Scale sales expected slightly above last year, but EBIT to be lower due to higher operational costs and less R&D capitalization.
HBS sales expected higher, with EBIT still negative but improving significantly year-over-year.
Positive EBITDA impact anticipated from cost reductions, efficiency gains, potential tariff refunds, and favorable FX developments.
Guidance subject to changes in trade restrictions, geopolitical tensions, tariffs, and currency effects.
Latest events from SMA Solar
- 2025 revenue was flat, losses deepened on one-offs, but cash flow and 2026 outlook improved.S92
Q4 202526 Mar 2026 - Large Scale growth offsets Home and C&I declines; cash flow and outlook remain pressured.S92
Q2 20242 Feb 2026 - Sharp sales and earnings drop, major restructuring, but Large Scale segment outperforms.S92
Q3 202414 Jan 2026 - 2024 sales and EBITDA declined, but restructuring aims for recovery and EBIT improvement in 2025.S92
Q4 202424 Dec 2025 - Large Scale growth offset weak Home and C&I, with cautious outlook amid tariff and market risks.S92
Q1 202525 Nov 2025 - Sales and margins fell in H1 2025, but cash flow and restructuring efforts improved outlook.S92
Q2 202523 Nov 2025 - Large Scale growth offset by HBS losses and major restructuring; outlook remains challenging.S92
Q3 202517 Nov 2025 - Revenue and earnings fell sharply in 2024, driving a renewed focus on efficiency and innovation.S92
AGM 2025 Presentation1 Jul 2025